World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies in the World as of Jul. 01, 2024

Rank Company Market Cap (USD) Country Sector Industry
361 C4 Therapeutics, Inc. $311.0 M United States US Healthcare US Biotechnology
362 Avacta Group plc $308.0 M United Kingdom UK Healthcare UK Biotechnology
363 Taiwan Liposome Company, Ltd. $302.9 M

(Sept. 1, 2021)

Taiwan Taiwanese Healthcare Taiwanese Biotechnology
364 Amarin Corporation plc $302.6 M Ireland Irish Healthcare Irish Biotechnology
365 Xiangxue Pharmaceutical Co.,Ltd. $300.2 M China Chinese Healthcare Chinese Biotechnology
366 Oyster Point Pharma, Inc. $299.9 M

(Dec. 1, 2022)

United States US Healthcare US Biotechnology
367 Bioventix plc $299.7 M United Kingdom UK Healthcare UK Biotechnology
368 XOMA Corporation $298.3 M United States US Healthcare US Biotechnology
369 Poseida Therapeutics, Inc. $293.5 M United States US Healthcare US Biotechnology
370 Foghorn Therapeutics Inc. $293.2 M United States US Healthcare US Biotechnology
371 Alphamab Oncology $290.4 M China Chinese Healthcare Chinese Biotechnology
372 Ryvu Therapeutics SA $290.2 M Poland Polish Healthcare Polish Biotechnology
373 Nautilus Biotechnology, Inc. $288.1 M United States US Healthcare US Biotechnology
374 Cerecor Inc. $285.0 M

(June 1, 2022)

United States US Healthcare US Biotechnology
375 ALX Oncology Holdings Inc. $283.9 M United States US Healthcare US Biotechnology
376 Enanta Pharmaceuticals, Inc. $283.6 M United States US Healthcare US Biotechnology
377 Shenzhen Bioeasy Biotechnology Co. Ltd $280.7 M China Chinese Healthcare Chinese Biotechnology
378 Chempartner Pharmatech Co. Ltd $279.2 M China Chinese Healthcare Chinese Biotechnology
379 Revance Therapeutics, Inc. $278.9 M United States US Healthcare US Biotechnology
380 Inozyme Pharma, Inc. $277.7 M United States US Healthcare US Biotechnology
381 Zhejiang Wecome Pharmaceutical Company Ltd $276.4 M China Chinese Healthcare Chinese Biotechnology
382 Atea Pharmaceuticals, Inc. $273.7 M United States US Healthcare US Biotechnology
383 Savior Lifetec Corp $270.3 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
384 Immutep Limited $266.4 M Australia Australian Healthcare Australian Biotechnology
385 Panion & Bf Biotech, Inc. $264.7 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
386 Imugene Limited $264.1 M Australia Australian Healthcare Australian Biotechnology
387 MacroGenics, Inc. $263.1 M United States US Healthcare US Biotechnology
388 MeiraGTx Holdings plc $258.5 M United States US Healthcare US Biotechnology
389 Zentalis Pharmaceuticals, Inc. $257.1 M United States US Healthcare US Biotechnology
390 Chiasma, Inc. $253.0 M

(July 1, 2021)

United States US Healthcare US Biotechnology

Top Biotechnology Companies in the World as of Jul. 01, 2024

361. C4 Therapeutics, Inc.

Company Profile: C4 Therapeutics, Inc.
Market Cap (USD): $311.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

362. Avacta Group plc

Company Profile: Avacta Group plc
Market Cap (USD): $308.0 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

363. Taiwan Liposome Company, Ltd.

Company Profile: Taiwan Liposome Company, Ltd.
Market Cap (USD): $302.9 M (Sept. 1, 2021)
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

364. Amarin Corporation plc

Company Profile: Amarin Corporation plc
Market Cap (USD): $302.6 M
Country: Ireland
Sector: Irish Healthcare
Industry: Irish Biotechnology

365. Xiangxue Pharmaceutical Co.,Ltd.

Company Profile: Xiangxue Pharmaceutical Co.,Ltd.
Market Cap (USD): $300.2 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

366. Oyster Point Pharma, Inc.

Company Profile: Oyster Point Pharma, Inc.
Market Cap (USD): $299.9 M (Dec. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

367. Bioventix plc

Company Profile: Bioventix plc
Market Cap (USD): $299.7 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

368. XOMA Corporation

Company Profile: XOMA Corporation
Market Cap (USD): $298.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

369. Poseida Therapeutics, Inc.

Company Profile: Poseida Therapeutics, Inc.
Market Cap (USD): $293.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

370. Foghorn Therapeutics Inc.

Company Profile: Foghorn Therapeutics Inc.
Market Cap (USD): $293.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

371. Alphamab Oncology

Company Profile: Alphamab Oncology
Market Cap (USD): $290.4 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

372. Ryvu Therapeutics SA

Company Profile: Ryvu Therapeutics SA
Market Cap (USD): $290.2 M
Country: Poland
Sector: Polish Healthcare
Industry: Polish Biotechnology

373. Nautilus Biotechnology, Inc.

Company Profile: Nautilus Biotechnology, Inc.
Market Cap (USD): $288.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

374. Cerecor Inc.

Company Profile: Cerecor Inc.
Market Cap (USD): $285.0 M (June 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

375. ALX Oncology Holdings Inc.

Company Profile: ALX Oncology Holdings Inc.
Market Cap (USD): $283.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

376. Enanta Pharmaceuticals, Inc.

Company Profile: Enanta Pharmaceuticals, Inc.
Market Cap (USD): $283.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

377. Shenzhen Bioeasy Biotechnology Co. Ltd

Company Profile: Shenzhen Bioeasy Biotechnology Co. Ltd
Market Cap (USD): $280.7 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

378. Chempartner Pharmatech Co. Ltd

Company Profile: Chempartner Pharmatech Co. Ltd
Market Cap (USD): $279.2 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

379. Revance Therapeutics, Inc.

Company Profile: Revance Therapeutics, Inc.
Market Cap (USD): $278.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

380. Inozyme Pharma, Inc.

Company Profile: Inozyme Pharma, Inc.
Market Cap (USD): $277.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

381. Zhejiang Wecome Pharmaceutical Company Ltd

Company Profile: Zhejiang Wecome Pharmaceutical Company Ltd
Market Cap (USD): $276.4 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

382. Atea Pharmaceuticals, Inc.

Company Profile: Atea Pharmaceuticals, Inc.
Market Cap (USD): $273.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

383. Savior Lifetec Corp

Company Profile: Savior Lifetec Corp
Market Cap (USD): $270.3 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

384. Immutep Limited

Company Profile: Immutep Limited
Market Cap (USD): $266.4 M
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

385. Panion & Bf Biotech, Inc.

Company Profile: Panion & Bf Biotech, Inc.
Market Cap (USD): $264.7 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

386. Imugene Limited

Company Profile: Imugene Limited
Market Cap (USD): $264.1 M
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

387. MacroGenics, Inc.

Company Profile: MacroGenics, Inc.
Market Cap (USD): $263.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

388. MeiraGTx Holdings plc

Company Profile: MeiraGTx Holdings plc
Market Cap (USD): $258.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

389. Zentalis Pharmaceuticals, Inc.

Company Profile: Zentalis Pharmaceuticals, Inc.
Market Cap (USD): $257.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

390. Chiasma, Inc.

Company Profile: Chiasma, Inc.
Market Cap (USD): $253.0 M (July 1, 2021)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology